Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

PURPOSE: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after CRT for stage III NSC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Radiat Oncol
Main Authors: Vyfhuis, Melissa A.L., Bhooshan, Neha, Burrows, Whitney M., Turner, Michelle, Suntharalingam, Mohan, Donahue, James, Nichols, Elizabeth M., Feliciano, Josephine, Bentzen, Søren M., Badiyan, Shahed, Carr, Shamus R., Friedberg, Joseph, Simone, Charles B., Edelman, Martin J., Feigenberg, Steven J., Mohindra, Pranshu
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
ROI Value of RT Publication Award Winner
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://ncbi.nlm.nih.gov/pubmed/29114590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2017.07.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados